Introduction
Granulocyte colony-stimulating factor (G-CSF) is a crucial regulator of granulopoiesis by stimulating the proliferation, survival and maturation of myeloid progenitor cells. The effects of G-CSF are mediated through a specific cell-surface receptor, the granulocyte colony-stimulating factor receptor (G-CSF-R). 1 The membrane-proximal region of the G-CSF-R contains two conserved sequences, called Box 1 and Box 2, as well as a more distal and less-conserved Box 3 region. In addition, the cytoplasmic domain of the human G-CSF-R contains four conserved tyrosine residues (Y704, Y729, Y744 and Y764) that serve as potential docking sites for Src homology 2 (SH2) domains of signaling proteins. 2, 3 Pathways known to be stimulated by the G-CSF-R include the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathway, [4] [5] [6] [7] [8] the Ras/Raf/MEK/mitogen-activated protein kinase (MAPK) pathway [9] [10] [11] [12] [13] and the phosphatidylinositol (PI) 3-kinase/Akt pathway. [14] [15] [16] We have previously identified a subset of severe congenital neutropenia (SCN) patients that harbor acquired mutations in the gene encoding the G-CSF-R, which serve to truncate the carboxyl-terminus of the receptor. [17] [18] [19] [20] This cohort of patients also exhibits a strong predisposition to acute myeloid leukemia (AML). 1 Although the role of G-CSF-R truncations in the etiology of SCN remains controversial, [21] [22] [23] [24] [25] there has been little argument about the contribution of such mutations to leukemogenesis. Truncated receptors show normal affinity for G-CSF, 17 but transduce a strong hyperproliferative signal but a defective maturation signal when expressed in myeloid cells, 19 a result confirmed in mice expressing truncated G-CSF-Rs. 22, 25, 26 We and others have shown that this hyperproliferation is due, at least in part, to defective internalization, [27] [28] [29] as well as the loss of the receptor docking site for a string of negative regulators, including Src homology domain phosphatase-1, SH2 domain-containing 5 0 -phosphatase, cytokine-induced Src homology 2-containing protein and suppressor of cytokine signaling 3. [29] [30] [31] Collectively, this leads to a decreased 'offrate' 26, 27, 32 and extended activation of various signaling pathways. 15, 26, 27, 29, 32 However, those signaling pathways actually responsible for the hyperproliferation have remained unknown. Here, we utilize receptor mutants, dominant-negative STATs and pharmacologic inhibitors to show that sustained STAT5 activation, probably via JAK2, is the major mediator of the hyperproliferative responses, with a lesser contribution from the MAPK/extracellular signal-regulated kinase kinase (MEK) and PI 3-kinase pathways.
Materials and methods

Cell culture
A subline of the interleukin (IL)-3-dependent murine myeloid cell line 32Dcl3, called 32D.cl8.6, 27 and derivatives thereof were maintained in Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 10% (v/v) fetal bovine serum (FBS) and 10 ng/ml of murine IL-3, at 371C and 5% (v/v) CO 2 . Bone marrow cells were obtained from gcsfr-D715/D715 mice, as described. 22 Where necessary, cells were deprived of serum and growth factors for 4 h at 371C in RPMI 1640 medium at a density of 2-4 Â 10 6 per ml and then stimulated with 100 ng/ml human G-CSF.
Plasmid construction, transfections and infections
Cloning of wild-type (WT) GCSFR cDNA, the truncation mutant mM1 (d685) and the SCN patient-derived truncation mDA (d715) into the eucaryotic expression vector pLNCX has been described previously. 8 These constructs were linearized by PvuI digestion and transfected into 32D.cl8.6 cells by electroporation. After 48 h incubation, cells were selected with G418 (Gibco-BRL, Invitrogen, Glen Waverley, Australia) at a concentration of 0.8 mg/ml with multiple clones expanded for further analysis. Equivalent receptor expression was determined for multiple independent clones using anti-G-CSF-R antibodies, as described. 8 For retroviral infections, pMX clones were generated containing mSTAT5A(WT) and mSTAT5AD750(DN) 33 cloned upstream of an IRES-enhanced green fluorescent protein (EGFP) and transfected into the Phoenix A amphotrophic packaging cell line (ClonTech, Palo Alto, CA, USA) to produce recombinant retrovirus, following standard protocols. Virus supernatants were used to infect 32D cells harboring the pLNCX.GCSFR(mDA) vector utilizing RetroNectin (Takara Biomedicals, Shiga, Japan), as described by the manufacturer. After 48 h, puromycin was added to 1 mg/ml to select for stably transduced cells. EGFP expression levels were assessed by flow cytometry using a FACScan and sterile sorted using a fluorescence-activated cell sorter (FACS)-Calibur (Becton Dickinson, San Jose, CA, USA). For STAT3 experiments, stable 32D clones were generated by transfecting a pBabe clone of mutant mDA followed by puromycin selection and subsequent confirmation of expression, as described above. A positive clone was subsequently co-transfected with either pCAGGS-Neo or pCAGGS-Neo.HA-STAT3F 34 and clones selected using neomycin and screening for STAT3 expression using immunoprecipitation-Western blot analysis (see below).
Cell proliferation, cell cycle, apoptosis and morphological analysis
To quantify proliferation, cells were incubated at an initial density of 1-2 Â 10 5 cells/ml in 10% FBS/RPMI medium supplemented with 100 ng/ml of human G-CSF or 10 ng/ml of murine IL-3 and viable cells counted on the basis of Trypan blue exclusion. Where necessary, the medium was replenished every 1-2 days, and the cell densities were adjusted to 1-2 Â 10 5 cells/ ml. Alternatively, cells were washed thoroughly before incubation in triplicate wells of a 96-well plate at 1 Â 10 6 cells/ml with appropriate growth factors for 30 h and pulsed with methyl-3 H-thymidine for the last 24 h. In some studies, inhibitors of PI 3-kinase (LY294002), MEK (PD098059) or JAK2 (AG490), or vehicle (dimethyl sulphoxide (DMSO)), were added to these cultures. Cells were analyzed for DNA content with propidium iodide (PI) 35 and for apoptosis with PI/Annexin V, 36 using an Annexin V-FITC Apoptosis Detection Kit (Sigma-Aldrich, Castle Hill, Australia). To analyze the morphological features, cells were spun onto glass slides and examined after May-Grü nwaldGiemsa staining.
Electrophoretic mobility shift assay
Nuclear extracts were prepared from appropriate cell populations as described. 8 . For electrophoretic mobility shift assay (EMSA) analysis, extracts from approximately 0.4-0.5 Â 10 6 cells were incubated for 20 min at room temperature with 0.2 ng of 32 P-labeled double-stranded oligonucleotide: m67 (5 0 -CATT TCCCGTAAATC), a high-affinity mutant of the sis-inducible element of the human c-fos gene, 37 which binds STAT1 and STAT3, or b-cas (5 0 -AGATTTCTAGGAATTCAATCC), derived from the 5 0 region of the b-casein gene, 33 which binds STAT5 and STAT1. The DNA complexes were separated by electrophoresis on 5% (w/v) polyacrylamide gels containing 5% (v/v) glycerol in 0.25 Â Tris-Borate-ethylenediaminetetraacetic acid (EDTA) as described. 8 The gels were dried and subsequently analyzed by autoradiography.
Preparation of cell lysates, immunoprecipitation and Western blotting
Cells were washed with 10 volumes of ice-cold phosphate buffered saline (PBS) supplemented with 10 mmol/l Na 3 VO 4 , and lyzed by incubation for 30 min at 41C in lysis buffer (20 mmol/l Tris-HCl, pH 8.0, 137 mmol/l NaCl, 10 mmol/l EDTA, 100 mmol/l NaF, 1% Nonidet P-40, 10% glycerol, 2 mmol/l Na 3 VO 4 , 1 mmol/l Pefabloc SC, 50 mg/ml aprotinin, 50 mg/ml leupeptin, 50 mg/ml bacitracin and 50 mg/ml iodoacetamide). Insoluble materials were removed by high-speed centrifugation for 15 min at 41C. Immunoprecipitation and Western blotting was performed as described. 8 Antibodies used were: anti-STAT3C (Santa Cruz, Santa Cruz, CA, USA), anti-HA (12CA5) (Roche, Dee Why, Australia), anti-pERK (E4) (Santa Cruz); anti-ERK (K-23) (Santa Cruz), anti-pAkt (Thr 308) (New England Biolabs, Beverly, MA, USA), and anti-Akt (New England Biolabs).
Results
Analysis of G-CSF-R mutants
We have previously established the murine myeloid 32D cell line as a useful model for assessing the biological effects mediated by the G-CSF-R, including the identification of strong hyperproliferative responses induced by truncated G-CSF-Rs derived from patients with SCN/AML, 3, 11, 19, 27 typified by mDA ( Figure 1a ). To further elucidate the regions of the receptor responsible for the hyperproliferative phenotype, an additional mutant mM1, which deletes all sequences beyond Box 2 ( Figure 1a ), was also analyzed using the 32D cell model. Clones expressing equivalent levels of receptor ( Figure 1b) were analyzed for their responsiveness to G-CSF (Figure 1c and d). As described previously, 3 the WT G-CSF-R mediates a transient proliferative response, followed by differentiation into morphologically identifiable neutrophilic granulocytes, whereas the SCN-derived mDA leads to sustained proliferation with no differentiation. In contrast, cells expressing the more severely truncated mutant mM1 showed no differentiation and limited proliferation, which ceased after 6-8 days on G-CSF. Therefore, the region spanning residues 684-715 appears essential for the sustained proliferation from truncated mDA receptors.
STAT activation by G-CSF-R mutants
As STATs have been implicated in the control of differentiation and proliferation from the WT G-CSF-R, 3, 7, 8, [38] [39] [40] we analyzed STAT activation from these various receptor forms. Whereas both WT and mDA receptors strongly activated STAT3 in both short-term ( Figure 2a ) and long-term (Figure 2b ) assays, the mM1 form produced negligible activation in either assay, consistent with a role for Y704 in facilitating STAT3 docking. 8 In contrast, the control of STAT5 activation was more complex. Short-term activation of STAT5 from WT receptors was strong but transient, whereas from SCN-derived mDA receptors it was strong and sustained, as previously reported. 27 In contrast, mM1 activated moderate levels of STAT5, indicating that both the membrane proximal region and residues 684-715 contribute to STAT5 activation. However, like mDA, the kinetics of activation from mM1 was sustained relative to the WT receptor in these shortterm assays (Figure 2a ). This is consistent with the notion that receptor truncation leads to loss of a di-leucine internalization motif 27, 28 and binding sites for negative regulators that collectively lead to sustained signaling. [29] [30] [31] However, longterm activation of STAT5 from mM1 was similar to the WT receptor, being considerably lower than the robust activation from mDA, suggesting other mechanisms might control STAT5 activation over more extended periods.
Role of STAT3 and STAT5 in hyperproliferation responses from truncated receptors
The collective results described above suggested that robust activation of STAT5, rather than STAT3, might contribute to the hyperproliferative responses of truncated receptors. To directly address this question, we separately introduced dominantnegative forms of these two STAT proteins into 32D[mDA] cells to assess their effects. Clones containing empty vector (mDA [vec] ) or expressing HA-tagged dominant-negative STAT3 (mDA[S3F]) ( Figure 3a) were compared for their responses to growth factors. No difference was observed in IL-3 responses between the clones (data not shown). However, clones expressing the dominant-negative STAT3 showed a slight, but statistically significant, increase in proliferation in response to G-CSF (Figure 3b) . None of the clones produced appreciable differentiation (data not shown).
To examine the role of STAT5, a similar strategy was employed to that described for STAT3. However, despite several rounds of transfection, no clones showed reduced STAT5 were 
Role of other pathways in hyperproliferative responses
The results described above suggested a positive role for STAT5 in mediating the hyperproliferative responses of truncated G-CSF-Rs. However, previous studies have shown that truncated G-CSF-Rs also produce sustained activation of both extracellular signal-regulated kinase (ERK) and Akt, 15, 16 a result confirmed in our 32D[mDA] clones (data not shown). To assess the relative effects of these pathways on the hyperproliferative responses of truncated receptors, we used specific pharmacological agents, LY294002, PD098059 and AG490, targeting the kinases PI 3-kinase (upstream of Akt), MEK (upstream of ERK) and JAK2 (upstream of STAT5), respectively. The JAK2 inhibitor was the most potent inhibitor of proliferation, causing a 85-95% reduction when used at 20 mM (Figure 5a and b) . In contrast, the MEK inhibitor resulted in a reduction of approximately 40-50% at 10-40 mM, whereas the PI 3-kinase inhibitor inhibited proliferation by 30-40% at 12.5-50 mM. Each was effective in 32D[mDA] cells at these concentrations, as judged by inhibition of activation of the respective downstream signaling molecule (Figure 5c-e) . The JAK2 inhibitor produced similar levels of inhibition of 32D[WT] cells (data not shown). Analysis of the cell cycle profile revealed no gross changes in the presence of the inhibitors, with only a small increase in the S-and G2/M-phase content observed with AG490 (Figure 5f ). Again, only AG490 caused any appreciable increase in apoptosis (Figure 5g ), although this was still small, and insufficient to explain the inhibition of cell growth as judged by thymidine incorporation and Trypan blue exclusion. Interestingly, in mDA[S5dn] cells, the relative potency of the MEK and PI 3-kinase inhibitors increased (Figure 5h ), suggesting that these pathways act synergistically with the STAT5 pathway. Application of the inhibitors to bone marrow cells of gcsfr-D715/D715 mice, which carry a knock-in mutation equivalent to mDA, 22 largely recapitulated the inhibitor results seen in 32D[mDA] cells (Figure 5i ), confirming their in vivo relevance.
Discussion
The results presented here show unequivocally in the 32D cell model that sustained STAT5 activation, most probably via JAK2, is a key mediator of the hyperproliferative responses triggered by truncated G-CSF-Rs. In addition, signaling via other pathways, including those involving both PI 3-kinase and MEK, also appears to make a contribution to the enhanced mitogenic response. In contrast, STAT3 appears to exert a negative influence, in agreement with recent studies showing that STAT3 inhibits proliferative responses in the context of the full-length G-CSF-R. 40, 41 Therefore, it is likely that the consequences of receptor truncation are a result of the net effect of a complex combination of signals, at least in 32D and gcsfr-D715/D715 cells, although it remains to be confirmed in primary cells from appropriate SCN/AML patients.
The PI 3-kinase/Akt pathway has been shown to be an important component of oncogenic signaling generally. For example, its activation is required for Ros-induced cell transformation, 42 and it also contributes to the mitogenic signaling from the oncogenic Xmrk. 43, 44 Studies in chicken B cells suggest that it has a role in proliferation as well as survival Hyperproliferative pathways from truncated G-CSF receptors J Gits et al signaling from the full-length G-CSF-R, 45 whereas others have shown that PI 3-kinase is activated by G-CSF and correlates with inhibition of apoptosis.
14 Furthermore, one of the key signaling molecules downstream of PI 3-kinase, Akt, has been shown to be activated in a sustained manner by truncated G-CSF-Rs. 15, 16 Our results show that this prolonged activation of the PI 3-kinase/Akt pathway probably also contributes to proliferative signaling in the context of the truncated G-CSF-R. The p21 ras /MEK/MAPK pathway is also a key component of mitogenic responses in a wide variety of cell systems. 46 Moreover, several studies have also implicated components of the p21 ras /MEK/MAPK pathway in proliferative responses from the full-length G-CSF-R, including the upstream signaling molecules Shc, Grb2 and SHP-2, 2,3,47 , p21 ras itself, 10, 11, 48, 49 MEK 50,51 and ERK. 13, 51 In addition, expression of dominantnegative p21 ras is able to inhibit G-CSF-mediated proliferation without affecting differentiation. 48 In the context of the fulllength receptor, the p21 ras /MEK/MAPK pathway is abrogated by removal of the C-terminal tyrosine, Y764, which also blocks proliferation but not differentiation. 11, 13 The truncated mDA receptor, on the other hand, is able to activate this pathway despite the absence of this tyrosine. 32 Interestingly, unlike other pathways, activation of ERK by mDA is similar in extent and length to that seen from the WT receptor, 32 perhaps providing some explanation for why inhibitors of this pathway only exert a reduced effect on proliferation.
Perturbed activation of JAK-STAT pathway components has been associated with several hematopoietic disorders. 52 From these studies, it is clear that hyperactivation of JAK2 results in myeloproliferative disorders 53 and constitutive STAT5 activation is consistently observed in leukemia (compared to STAT3 in lymphoma). 52 In addition, STAT5 appears to be essential for the myelo-and lymphoproliferative disease induced by TEL-JAK2 fusions, 54 and is also required for cell cycle progression, survival and leukemogenesis induced by BCR-ABL. 55, 56 Potential roles in other cancers have also been identified, including melanoma 44 and mammary cancer. 57 By corollary, expression of constitutively active forms of STAT5 has been shown to result in enhanced proliferation of myeloid cell lines 38 and of hematopoietic cells in vivo, 58 which we have recently confirmed. 59 The results presented here showing sustained STAT5 activation downstream of JAK2 as a crucial mediator of the hyperproliferative responses from truncated G-CSF-Rs associated with AML further emphasizes the importance of the JAK2-STAT5 module in malignancy -a role that has apparently been conserved throughout evolution. 59, 60 This is perhaps not surprising given the important cell cycle regulators known to be stimulated by STAT5, including cyclin D1 61 and c-myc, 62 not to mention its positive effects on cell survival mediators, such as bcl-XL and bcl-2. 56, 63 Together, this suggests that suppression of STAT5 function may represent an important general strategy in the treatment of leukemias and other cancers.
However, our results also point to a conspiracy of pathways being required to mediate full proliferative potency from truncated G-CSF-Rs, which appears to be a common theme in oncogenesis. For example, the full mitogenic signaling potency from the oncogenic Xmrk kinase is apparently also mediated by PI 3-kinase, MAPK and STAT5 pathways. 43, 44 The challenge remains to delineate the exact contribution of each of these pathways to the transformation process at the molecular level, which is finally become a reality using microarray and other technologies. [mDA] cells were starved for 4 h before stimulation for 10 min with ( þ ) or without (À) G-CSF (100 ng/ml), in the presence of specific inhibitors of PI 3-kinase (c), MEK (d) and JAK2 (e). Total cell lysates subjected to Western blot analysis with activation-specific antibodies for the downstream signaling molecules Akt (PI 3-kinase -c) and ERK (MEK -d). Membranes were subsequently stripped and reprobed with a corresponding antibody to detect total Akt and total ERK, respectively. Alternatively, nuclear extracts were analyzed for activation of STAT5 and STAT3 using the probes b-cas (e -upper panel) and m67 (e -lower panel). This was a representative of three experiments. (f and g) Analysis of cell cycle profile and apoptosis in the presence of inhibitors. 32D[mDA] cells were treated as described in panel a, and subjected to cell cycle analysis using PI-staining (f) and apoptosis analysis using PI/Annexin V (g). 
